Physician profile
Thomas E Hamilton
NPI 1386674703
$6,594.50
in general payments reported to CMS, 2019-2025
42 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $1,005 · 2021: $1,178 · 2022: $931 · 2023: $950 · 2024: $1,476 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,746 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,745.52 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $926.95 | 2021-2025 | |
| Glaxosmithkline, LLC. | $891.00 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $590.87 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $585.80 | 2019-2022 | |
| Novo Nordisk INC | $565.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $497.84 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $348.90 | 2019-2025 | Airsupra, Farxiga |
| Astellas Pharma US INC | $267.56 | 2019-2025 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $246.38 | 2021-2023 | Gattex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.80 | 2019-2024 | Synjardy, Jardiance |
| Allergan, INC. | $177.70 | 2019-2020 | |
| Inspire Medical Systems, INC. | $169.11 | 2024 | Inspire |
| Phathom Pharmaceuticals, INC. | $111.44 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $82.62 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.84 | 2020-2024 | Trulance, Xifaxan |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.